When should a DMA product review block a release?
As an internal control, block launch when the change affects a designated and the team cannot identify the applicable Article 5, 6, or 7 obligation, explain how the product meets it, show that anti-circumvention risks were reviewed, or locate the Article 11 evidence. The DMA does not prescribe this release-gate procedure; it requires the gatekeeper to ensure and demonstrate compliance.